Cure Alzheimer's Fund Cure Alzheimer's Fund

John S. Lazo, Ph.D.

Harrison Distinguished Professor Emeritus, Departments of Pharmacology and Chemistry, University of Virginia. 

Allegheny Foundation Professor Emeritus, Department of Pharmacology and Chemical Biology, University of Pittsburgh

Acclaimed for his work in molecular pharmacology and cancer drug research and drug discovery, Dr. Lazo is the recipient of many awards and honors.

Dr. Lazo graduated from The Johns Hopkins University with a bachelor of arts degree in chemistry and a Ph.D. in pharmacology from the University of Michigan. He received postdoctoral training at Yale University and was a member of the pharmacology faculty at Yale University (12 years), the University of Pittsburgh (24 years) and the University of Virginia (11 years). Dr. Lazo served as a corporate associate of Johnson & Johnson, has co-founded four biotechnology companies, has authored 11 books, published more than 300 scientific articles and reviews and has been the principal investigator on numerous research projects.

Related Research:

Funded Research

These projects were made possible from Cure Alzheimer's Fund support.

Project Description Researchers Funding
Adult Human iNeurons: A Next-Generation Drug Screening Platform for Alzheimer’s Disease 2020, 2021

$444,498
Targeting Cell Cycle Re-entry Using 3-D Neuron Cultures 2017 and 2018

$420,681
Cell Cycle Re-entry in 3-D Human Neuron Cultures 2015

$200,000

Selected Publications

These published papers resulted from Cure Alzheimer’s Fund support.

John S. Lazo, Kelley E. McQueeney, Elizabeth R. Sharlow New Approaches to Difficult Drug Targets: The Phosphatase Story, SLAS DISCOVERY, 22(9), Oct 2017, 1071-1083, Read More

George S.Bloom, John S.Lazo, Andrés Norambuena Reduced brain insulin signaling: A seminal process in Alzheimer’s disease pathogenesis, Neuropharmacology, 29 Sep 2017, Read More

Back to Our Researchers